CA-TALKDESK
4.8.2022 11:32:06 CEST | Business Wire | Press release
Talkdesk®, Inc. , a global contact center leader for customer-obsessed companies, and Microsoft are partnering to deliver a contact center solution for SD Worx . The leading European provider of people solutions selected Talkdesk with Microsoft Teams Connector because it will provide a future-proof platform with enhanced stability to support better customer experiences (CX) through richer agent collaborations.
With headquarters in Belgium, SD Worx has been delivering people solutions across the entire employee lifecycle for more than 75 years. Turning human resources (HR) into a source of value for their more than 80,000 clients across 150 plus countries worldwide, company leaders believe people are at the heart of any business success. SD Worx is driven by a desire to see not only their own global workforce of nearly 7,000 thrive and spark success, but also the five million plus employees they serve each month.
The existing SD Worx contact center operates with separate telephony and case management platforms. Those separate platforms, paired with a combined inbound and outbound volume of more than a million client calls each year, make the process for agents trying to simultaneously gather client insights and field client queries complicated. Talkdesk CX Cloud™, an end-to-end customer experience solution, will provide SD Worx with a modernized, cloud-based contact center platform that can grow with the company.
Additionally, Talkdesk Microsoft Teams Connector™ will enable deeper collaboration between contact center agents and other teams across the organization. Talkdesk for Salesforce™ will further streamline operations and enhance opportunities for personalized engagement across channels. The Talkdesk solution – providing deep integrations with these key platforms – will allow SD Worx agents to more proactively support clients with increased efficiency.
“When we design our contact center flows, I always try to picture myself as one of our clients,” said Yannick Lefever, product owner, SD Worx. “CX comes first here. It’s important to us that the whole customer journey is positive and productive from inquiry to conclusion, and the little details can make or break that experience for all involved. The Talkdesk solution will provide a more seamless experience for SD Worx agents and clients, ensuring that all those details align across platforms and customer touch points.”
“At Microsoft, we strive to exceed customer expectations,” said Mauro Xavier, general manager for partnership solutions, Microsoft. “Partnerships like the one we have with Talkdesk allow us to do exactly that. By integrating best in breed software – Talkdesk CX Cloud and Microsoft Teams – we were able to provide a unique value proposition to SD Worx, enhancing collaboration and enabling a better user experience.”
“For any industry – and especially people solutions – a successful, customer-centric approach to contact center operations hinges on the ability for departments, teams, and individual contact center agents to collaborate seamlessly,” said Tiago Paiva, chief executive officer, Talkdesk. “With the Talkdesk solution, SD Worx is prioritizing the kinds of collaborations across platforms that spark success among contact center agents, and translate to faster issue resolution for clients. We’re proud to partner with Microsoft and SD Worx to deliver exceptional CX for millions of employees every month.”
Additional Resources
- See Talkdesk recognized as a Leader in the 2021 Frost Radar™: European Contact Center as a Service Market analysis
- Hear from Talkdesk customers about why they selected Talkdesk CX Cloud and the difference it has made in their contact centers
- Save the date for the Talkdesk 2022 Opentalk CX Summit events in London and Madrid
Social Networks
- Web: https://www.talkdesk.com/customer-community/
- Blog: https://www.talkdesk.com/blog/
- Twitter: https://twitter.com/Talkdesk
- LinkedIn: https://www.linkedin.com/company/talkdesk/
- Facebook: https://www.facebook.com/Talkdesk/
- Instagram: https://www.instagram.com/Talkdesk/
About Talkdesk
Talkdesk® is a global cloud contact center leader for customer-obsessed companies. Our automation-first customer experience solutions optimize our customers’ most critical customer service processes. Our speed of innovation, vertical expertise, and global footprint reflect our commitment to ensuring that businesses can deliver better experiences across any industry and through any channel, resulting in higher customer satisfaction and accelerated business outcomes.
Talkdesk is a registered trademark of Talkdesk, Inc. All product and company names are trademarks™ or registered ® trademarks of their respective holders. Use of them does not imply any affiliation or endorsement by them.
About Microsoft
Microsoft (Nasdaq “MSFT” @microsoft) enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more.
About the Talkdesk partner ecosystem:
The Talkdesk global ecosystem represents a diverse network of best-in-class resellers, strategic alliance partners, cloud distributors, and technology vendors focused on providing a better way for organizations to create more meaningful and memorable moments with their customers. These partners support Talkdesk in helping customers across industries and around the world deliver customer experiences that build trust and loyalty.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220804005080/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
